Chimeric synthetic T cell receptor and antigen receptor receptors enable high-sensitivity T cell receptor-negative CD8αβ-CD3-positive T-cell development from human-induced pluripotent stem cells | Synapse
March 3, 2026Open Access
Chimeric synthetic T cell receptor and antigen receptor receptors enable high-sensitivity T cell receptor-negative CD8αβ-CD3-positive T-cell development from human-induced pluripotent stem cells
Key Points
The development involves high-sensitivity antigen receptors in T cell receptor-negative cells, enhancing specificity.
Significantly, the engineered T cells expressed CD8αβ and CD3, essential markers for T cell functionality.
This innovative method utilizes chimeric synthetic receptors for improved T cell responses, evident in lab studies.
Further research may validate usage in therapies targeting diseases like cancer and autoimmune disorders.